Harvest Integrated Research Organization (HiRO) has announced a strategic partnership through the signing of a memorandum of understanding (MOU) with CHA University Bundang Medical Center (CBMC) to deliver comprehensive solutions to pharmaceutical and biotech companies globally, covering all phases of clinical trials (Phase I to Phase IV).
The collaboration also aims to streamline trial processes, drive advancements, and foster innovation in healthcare research both regionally and globally. It also offers insights into the trials.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
CBMC is an institution within the CHA Medical Group.
The collaboration is set to cover feasibility assessments, principal investigator selection, and patient recruitment facilitation.
CHA Global Clinical Trials Center director Dr Young-Sang Kim said: “Through our partnership with HiRO, we are poised to elevate our clinical research expertise and medical excellence.
“Drawing on HiRO’s presence across the US, Europe, and the Asia-Pacific region, we are reinforcing our commitment to providing more effective and pioneering treatments on a global scale, ultimately improving outcomes for patients in need.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataHiRO is set to promote the clinical research capabilities of South Korea and CBMC on a global scale, emphasising the region’s facilities, ‘skilled’ professionals, and research ‘excellence’.
The organisations are committed to exploring innovative approaches together, with the MOU marking the beginning of a joint effort to shape the future of clinical research in South Korea and internationally.
HiRO founder and CEO Dr Karen Chu said: “South Korea is a prime destination for clinical trials, with a robust healthcare infrastructure and favourable research environment.
“We are confident that this partnership will further enhance our ability to offer capital-efficient and high-quality clinical trial solutions, leading to impactful results and significant advancements in medical breakthroughs.”
HiRO offers a full spectrum of cross-border solutions and services to its clients. These services include early pre-clinical strategic planning, clinical trial design, pharmacovigilance, regulatory affairs, statistics, management of data and projects, and clinical and medical monitoring services.
